We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 16

Directive on cross-border healthcare adapted by Europe
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • April 14 2011

The European Parliament and Council of Ministers have formally adopted the directive on patients' rights in cross-border healthcare following a number of European Court decisions over the past 10 years including the Watts case


New procurement directives come into force
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • April 17 2014

New EU procurement directives come into force today, 17 April 2014. The UK government now has two years to implement the new rules into national law


Clinical trials - greater transparency and uniformity across Europe
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • August 11 2014

The trend in clinical research is increasingly global. This means that, as well as multi-country trials becoming more common, there is competition


An update on PIP implants
  • Mills & Reeve LLP
  • European Union, France, United Kingdom
  • April 24 2014

In 1997, French company Poly Implant Prothèse (PIP) gained CE mark approval to produce breast implants using medical grade silicone. CE marking is


Cosmetic interventions and regulation
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • January 20 2014

While group litigation concerning the issues around PIP implants continues, there were developments last month in the ongoing discussions around the


General Medical Council (GMC) tells European Commission language competency should be a pre requisite to registration for doctors
  • Mills & Reeve LLP
  • United Kingdom, European Union
  • April 14 2011

In its formal response to the European Commission's Public Consultation on the Recognition of Professional Qualification Directive, the GMC stresses the need for more information about the nature and content of medical training and skills knowledge and competencies required of trained doctors in other member states to enable it to be assured of the quality of education outside of the UK


Challenge to seclusion policy on the basis of human rights
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • September 17 2012

Following an unsuccessful application to the House of Lords, Colonel Munjaz (a patient detained under the Mental Health Act 1983) challenged the legality of Ashworth Hospital’s seclusion policy on the grounds that it violated his human rights as set out in the European Convention on Human Rights


Change in the law a bar to ovarian tissue replacement?
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • March 20 2012

A young woman, Miss Oliver, whose ovarian tissue was removed and cryopreserved before she began chemotherapy for Ewing’s sarcoma as a teenager, has discovered that a change in the law in the intervening period may prevent Leeds Teaching Hospitals NHS Trust from replanting the tissue to overcome the fact that she was left infertile by the treatment for cancer


HL committee publishes report on mobility of healthcare professionals in the EU
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • December 13 2011

In the August edition of the Health Legal Update, we reported that evidence was being heard by the House of Lords Social Policies and Consumer Protection European Union sub-committee on the mobility of healthcare professionals within the EU


Patient matters supply of medicines - NHS permitted under EU law to incentivise money-saving prescribing practices
  • Mills & Reeve LLP
  • European Union, United Kingdom
  • June 14 2010

The European Court of Justice (ECJ) ruled in April in Association of the British pharmaceutical industry (ABPI) v Medicines and Healthcare Products Regulatory Agency (MHRA) case C-6209) that an incentive scheme operated by certain NHS bodies in England and Wales in a bid to reduce costs relating to prescription medicines did not breach European Union (EU) law